12 JUNE 2024

Side event: GSTHR Roadshows, Wednesday

THR at the Crossroads in LATAM, part 1

Country regulatory update

This event will provide valuable insights into the current state of vaping across Latin America, with a focus on health. The seminar is part of the Global State of Tobacco Harm Reduction programme.

Simultaneous translation (EN/ES) will be available.

Moderator

Francisco Ordóñez

Francisco Ordóñez

Panellist (Chile)

Ignacio Leiva

Ignacio Leiva

Panellist (Mexico)

Tomas O'gorman

Tomas O'gorman

Panellist

Tomasz Jerzyński

Tomasz Jerzyński

THR at the Crossroads in LATAM, part 2

Health, science, sustainability and human rights

This event will provide valuable insights into the current state of vaping across Latin America, with a focus on health. The seminar is part of the Global State of Tobacco Harm Reduction programme.

Simultaneous translation (EN/ES) will be available.

Moderator

Gina Reyes

Gina Reyes

Panellist (Argentina)

Diego Verrastro

Diego Verrastro

Panellist (Mexico)

Juan José Cirión

Juan José Cirión

Panellist (Mexico)

Roberto Sussman

Roberto Sussman

Panellist

Boris Platonoff

Boris Platonoff

Taxation, Regulation and THR – Delivering for Better Health

The GSTHR Road Show event will look at the vital role taxation and regulation can play in helping people move on from smoking.

With an expert panel, including policy and legal experts as well as those with experience or different national approaches, this promises to be a unique opportunity to consider how these levers can be used to improve the lives of millions of smokers.

Simultaneous translation (EN/ES) will be available.

Panellist

David Sweanor

David Sweanor

Panellist

Clive Bates

Clive Bates

Panellist

Carissa Düring

Carissa Düring

Moderator

Arkadi Sharkov

Arkadi Sharkov

Panellist

Giorgi Mzhavanadze

Giorgi Mzhavanadze

Panellist

Alex Gogoana

Alex Gogoana

12 JUNE 2024

Pre-conference meetings, Wednesday

Consumer meeting - open

Host

Fiona Patten

Fiona Patten

13 JUNE 2024

Day 1, Thursday

Opening and Keynote #1 - Health and economic benefits of tobacco harm reduction

  • What does the current evidence tell us about the potential health and economic benefits of safer nicotine products?
  • How should we weight this evidence?
  • What more do we need to know, what is the prognosis for the future and what are the short and long-term costs of different policy alternatives?
  • How might legislators and regulators balance health and economic imperatives to achieve positive outcomes?
  • What factors might make for an effective legislative and regulatory framework?
  • How should future progress be monitored, and policies adjusted in response?

Host

Grzegorz Król

Grzegorz Król

Speaker

Andrzej Fal

Andrzej Fal

Respondent

Michelle Minton

Michelle Minton

Workshop EE & CA Session - From Oversight to Action: Addressing Smoking Rates in Vulnerable Populations (RU language w/ EN translation)

Russian language session with simultaneous English translation

It is widely recognized that smoking rates among key and vulnerable populations surpass those of other groups. However, across much of the globe, support services often overlook this issue. Consequently, many will face mortality not due to their substance use or mental health conditions, but rather as a result of smoking-related diseases. This session aims to discuss the reasons for this oversight, with a particular emphasis on Eastern Europe and Central Asia, and to generate ideas for effective interventions to address this critical issue.

Host

Kasia Kowalczyk

Kasia Kowalczyk

Speaker

Alla Bessonova

Alla Bessonova

Speaker

Gintautas-Yuozas Kentra

Gintautas-Yuozas Kentra

Speaker

Uladzimir Pikirenia

Uladzimir Pikirenia

Speaker

Jarkyn Shadymanova

Jarkyn Shadymanova

ISoNTech, part 1

Host

Martin Cullip

Martin Cullip

Workshop - Media engagement for consumers

Host

Nancy Loucas

Nancy Loucas

Host

Heneage Mitchell

Heneage Mitchell

Speaker

Lindsey Stroud

Lindsey Stroud

Science Lab #1

Host

Ian Jones

Ian Jones

Author & presenter

Carrie Wade

Carrie Wade

Title: Estimating HPHC Exposure on a “Per Stick Basis”

Presenter

Karin Jacobson

Karin Jacobson

Title: Comprehensive Literature Review on the Indoor Air Quality Studies for Heated Tobacco Products (by Yoko Miyamoto)

Presenter

Marewa Glover

Marewa Glover

Title: Empowering Lady Health Workers for Smoking Cessation: Lessons from a Rural Pakistan Initiative (by Nazia Shaheen)

Presenter

Roberto Sussman

Roberto Sussman

Title: Reviews of Overheating ENDS Aerosol: Recent Updates (by Sebastien Soulet)

Presenter

Sud Patwardhan

Sud Patwardhan

Title: Bridging the policy-practice gap in tobacco cessation

Workshop - Smoking cessation in the 21st century

Host

Marewa Glover

Marewa Glover

ISoNTech, part 2

Host

Martin Cullip

Martin Cullip

Rhetoric, Regulation and Reality: consumer experience of the increasingly complex THR landscape

Despite considerable scientific evidence to support the efficacy - and relative safety - of safer nicotine products (SNPs) powerful voices continue to place obstacles in the way of consumers. Consumers are an often neglected voice in the debates that often result in disproportionate regulation, restrictions on sales and use and outright bans applied to SNPs. There are some notable exceptions, where consumers have had their voices heard and garnered support from legislators, resulting in a more balance and nuanced approach.

This session will attempt to ’take stock’ of where we are and what the next steps might look like, and will be consumer lead, with panellists from different regions reflecting on how the debate has been conducted and what influence they may have been able to bring to bear. What are the challenges and what strategies can have a positive impact? How can the science supporting SNPs be effectively promoted and how can the consumer experience be incorporated - ’nothing about us without us’? Who are the key actors and how might they be engaged in a constructive way? What can most effectively assist consumer advocacy to succeed?

Host

Tom Gleeson

Tom Gleeson

Speaker

Joseph Magero

Joseph Magero

Speaker

Ignacio Leiva

Ignacio Leiva

Speaker

Carissa Düring

Carissa Düring

Speaker

Asa Saligupta

Asa Saligupta

Science Lab #2

Host

Summer Hanna

Summer Hanna

Presenter

Ondrej Koumal

Ondrej Koumal

Title: Evolution of Tobacco Sales and Use Following Introduction of Heated Tobacco Products in Japan

Presenter

Tomasz Jerzyński

Tomasz Jerzyński

Title: Global Survey of Consumer Organizations Advocating for Safer Nicotine Products

Presenter

Andrea Patton

Andrea Patton

Title: Why Do Youth Use E-Cigarettes? Analysis of the National Youth Tobacco Survey 2016 to 2023

Presenter

Roberto Sussman

Roberto Sussman

Title: Environmental Vape Aerosol, Is It Harmful to Bystanders?

Panel Discussion #1 - The costs of prohibition

An examination of the health, social and economic costs of prohibition, with a panel reflecting on parallel experiences with illicit drugs and alcohol. The panel comprises politicians, thought leaders from the drug and alcohol fields and a consumer/vape trader perspective.

Host

Ethan Nadelmann

Ethan Nadelmann

Panellist

Fiona Patten

Fiona Patten

Panellist

Lindsey Stroud

Lindsey Stroud

Panellist

Sharifa Ezat Wan Puteh

Sharifa Ezat Wan Puteh

Panellist

Harry Shapiro

Harry Shapiro

Michael Russell Oration and Awards

Bridging the Divide: Taking Global Action to End Smoking

Host

David MacKintosh

David MacKintosh

Speaker

Cliff Douglas

Cliff Douglas

Awards Host

Gerry Stimson

Gerry Stimson

14 JUNE 2024

Day 2, Friday

Keynote #2 - Over/misinterpretation of the precautionary principle in relation to safer nicotine

Whilst no activity has a total absence of risk, science has to embrace risks and challenges to evolve. The over/misinterpretation of the precautionary principle is often an impediment to progress. Drawing on his experience of working with dependence in other fields, Dr McGovern will examine, in relation to nicotine use:

  • How should we categorise/quantify risk?
  • Is there a hierarchy of risk(s)?
  • What are the consequences of avoiding all risks?
  • How can equivalence assist in assessing risk?
  • Who should determine the limits of risk – for the individual and communities?

Are there lost opportunities for tobacco harm reduction to have a significant impact on personal and societal health improvement, due to the inappropriate application of the precautionary principle?

Host

Sarah Cooney

Sarah Cooney

Speaker

Garrett McGovern

Garrett McGovern

Respondent

Alex Wodak

Alex Wodak

Workshop - What does 'independent' mean, in relation to THR science?

Scientific data are critical to our understanding of the harm reduction potential of novel tobacco and nicotine products. Such data can be used in shaping evidence-based regulation and to inform consumers of the relative risks of tobacco product use. Increasingly, there are calls to preclude data generated by manufacturers in informing policy, as this data is seen by some as not ‘independent’ and biased by commercial goals. This panel session will explore:

  • What does independent mean when it comes to tobacco harm reduction science?
  • Why might manufacturers’ data not be acceptable?
  • Are manufacturers’ data on nicotine products any different from pharmaceutical industry data on novel drugs?
  • Does not being independent mean that we should not trust the data? Should we ignore it? Or just acknowledge it and move on without looking at it?
  • What are the dangers of ignoring evidence seen as ‘dependent’ and what does that mean for THR? Are there unintended consequences?
  • How do we move forward from here? How do we make sure both dependent and independent evidence is used to inform consumers and to help shape regulation?

Host

Ian Fearon

Ian Fearon

Speaker

Marewa Glover

Marewa Glover

Speaker

Sarah Cooney

Sarah Cooney

Speaker

George Hardie

George Hardie

Speaker

Colin Mendelsohn

Colin Mendelsohn

Science Lab #3

Host

Karin Jacobson

Karin Jacobson

Presenter

Rosalia Emma

Rosalia Emma

Title: Replica Project: A Journey Through Multicentric Research Endeavors

Presenter

Konstantinos Farsalinos

Konstantinos Farsalinos

Title: Flavored E-Cigarette Use at the Time of Quitting Smoking: Comparison Between Young Adults (18-24 Years Old) and Adults (>24 Years Old)

Presenter

Anna Masser

Anna Masser

Title: "Why Nicotine Content is not Nicotine Uptake”

Presenter

Elaine Round

Elaine Round

Title: Accelerating Towards A Smokeless World

Workshop - Regulation round up – global perspectives

Host

Barnaby Page

Barnaby Page

Speaker

Michael Landl

Michael Landl

Speaker

Peter Beckett

Peter Beckett

Speaker

Lindsey Stroud

Lindsey Stroud

Speaker (Pre-recorded video)

Alan Zhao

Alan Zhao

Speaker

David Yu

David Yu

Film Festival #1

Host

Emmanuel Mwape

Emmanuel Mwape

Workshop - LATAM Session (ES language w/ EN translation)

Spanish language session with simultaneous English translation

This workshop will explore the horizontal relationship of physicians, consumer advocates, and regulators to promote science-based communication and harm reduction alternatives to advance public health.

Host

Jeffrey Zamora

Jeffrey Zamora

Host

Carmen Escrig

Carmen Escrig

Speaker

Jorge Palma

Jorge Palma

Speaker

Diego Verrastro

Diego Verrastro

Speaker

Tomás O'Gorman

Tomás O'Gorman

Speaker

Fernando Bueno

Fernando Bueno

Film Festival #2

Host

Emmanuel Mwape

Emmanuel Mwape

Science Lab #4

Host

Summer Hanna

Summer Hanna

Presenter

Mirko Casu

Mirko Casu

Title: Digital and Mobile Health Innovations: Enhancing Smoking Detection and Cessation

Presenter

Chase Wallace

Chase Wallace

Title: Smoke Free Sweden 2023: Sweden Is About to Become the First Smoke-Free Country

Presenter

Colin Mendelsohn

Colin Mendelsohn

Title: What Are the Harms of Vaping in Young People Who Have Never Smoked

Presenter

Karin Jacobson

Karin Jacobson

Title: Navigating the Uncharted Waters of Unintended Consequences in Tobacco Regulation Policies

Presenter

Martin Fitzpatrick

Martin Fitzpatrick

Title: An Observational Study of a Heated Tobacco System Among Adult Smokers with No Intention to Quit

Workshop - Regulatory risk, investment and tobacco harm reduction

For Tobacco Harm Reduction (THR) to become widespread, affordable and appealing, reduced-risk alternatives to harmful tobacco products must be legally available and accessible. Achieving this requires sustained, substantial investment. The pace of harm reduction is closely tied to investment levels, influenced by potential risks and returns. Regulatory risk and uncertainty increase the returns required by investors, reducing available capital. Consequently:

  • Reduced Investment in Product Development: Lower investment hinders the development of safer and more appealing products supported by scientific research. Without this, regulators are unlikely to consider them as effective harm-reduction solutions, and existing RRPs do not appeal to most smokers.
  • Limited Accessibility in the Global South: Insufficient investment in cost reduction makes these products inaccessible to consumers in the Global South, home to 80% of harmful tobacco users.
  • Hesitancy to Enter High-Risk Markets: Companies and investors are less likely to enter markets with high regulatory risk

Host

Pieter Vorster

Pieter Vorster

Speaker

Sud Patwardhan

Sud Patwardhan

Speaker

Jonathan Fell

Jonathan Fell

Speaker

Marina Murphy

Marina Murphy

Panel Discussion #2 - Legislation and regulation - health and economic consequences

An examination of the health and economic impact of tobacco control measures and the role for proportionate regulation and risk management for alternative nicotine products.

Host

Clive Bates

Clive Bates

Panellist

David Sweanor

David Sweanor

Panellist

Nevena Crljenko

Nevena Crljenko

Panellist

Konstantinos Farsalinos

Konstantinos Farsalinos

Panellist

Joe Thompson

Joe Thompson

Film Festival Awards

Host

Emmanuel Mwape

Emmanuel Mwape

15 JUNE 2024

Day 3, Saturday

Keynote #3 - THR market influence - past, present and future

Vivien is a nicotine market specialist, and until recently, the Managing Director & Senior Analyst, Global Beverages, Tobacco and Cannabis, at TD Cowen, in New York City.
In her keynote she will address a number of themes, among them:

  • What factors prompted and drove initial investment in this field?
  • What is the state of the current market?
  • Who are the major investors/stakeholders?
  • What might be the impact of regulation – and possible prohibition – on future investment and the development of the next generation of safer nicotine products?
  • Are there lessons to be learnt from other emerging markets, for example the market for medicinal and recreational cannabis?

Host

David Sweanor

David Sweanor

Speaker

Vivien Azer

Vivien Azer

Respondent

Jonathan Fell

Jonathan Fell

Panel Discussion #3 - Rating the evidence - good and bad science

The hosts, together with a panel representing scientists, consumers and other stakeholders will review a selection of scientific papers, published in the past 12 months, on nicotine and THR-related issues, identifying the best and worst examples.

Host

Clive Bates

Clive Bates

Host

Arielle Selya

Arielle Selya

Panellist

Gizelle Baker

Gizelle Baker

Panellist

Roberto Sussman

Roberto Sussman

Panel Discussion #4 - The global culture war over THR

An examination of the nature of the THR debate, including different factions' objectives and the tactics being used, such as misinformation, emotive appeals and personal attacks. Panellists will share their own experiences, discuss why the debate is being conducted as it is, and ask how we should best operate in a challenging and often hostile environment.

Host

Will Godfrey

Will Godfrey

Panellist

Marewa Glover

Marewa Glover

Panellist

Rohan Sequeira

Rohan Sequeira

Panellist

Maria Papaioannoy-Duic

Maria Papaioannoy-Duic

Panellist

Christopher Snowdon

Christopher Snowdon

Closing remarks

Host

Jessica Harding

Jessica Harding